GlassScriptPhysician profile
Boris Volshteyn
NPI 1033107669
$1,314.95
in general payments reported to CMS, 2019-2025
15 companies · $701 in 2025
The $701 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.58 · 2021: $157 · 2022: $188 · 2023: $247 · 2024: $5.79 · 2025: $701.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $953.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $192.70 | 2025 | Daxxify |
| Polynovo North America LLC | $171.85 | 2023 | |
| Motiva USA, LLC | $169.62 | 2025 | |
| Tela Bio, INC. | $169.55 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Allergan, INC. | $144.63 | 2019-2021 | |
| Baudax Bio INC. | $124.77 | 2022 | |
| Convatec INC. | $115.64 | 2025 | |
| Ethicon US, LLC | $47.65 | 2022-2023 | Stratafix |
| Baxter Healthcare | $41.06 | 2023 | Floseal |
| Tactile Systems Technology INC | $34.81 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Acera Surgical, INC. | $29.10 | 2022 | |
| Cashflow Solutions, LLC | $28.11 | 2024-2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Vertex Pharmaceuticals Incorporated | $15.90 | 2025 | |
| Cardinal Health 200 LLC | $15.80 | 2021 | |
| Integra Lifesciences Corporation | $13.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boris Volshteyn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.